Deep Track Capital’s Immunic IMUX Stock Holding History

Deep Track Capital’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,831	Closed	-$774K	–	66
2023 Q2	$774K	Sell	30,831 -221,593	-88%	-$3.71M	0.04%	54
2023 Q1	$3.76M	Buy	+252,424	New	+$4.69M	0.15%	53

Other funds holding IMUX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Deep Track Capital's IMUX Position: Q3 2023 in Review

Deep Track Capital sold out of Immunic (IMUX) in Q3 2023, closing a stake of 30,831 shares — an estimated $774K sold.

Deep Track Capital first reported a position in IMUX in Q1 2023 and held it in 2 quarters. The position peaked at $3.76M in Q1 2023. 53 funds tracked by Wall St. Rank hold IMUX as of Q3 2023.

Deep Track Capital reported no remaining Immunic position as of Q3 2023 after selling out during the quarter.
Deep Track Capital sold 30,831 Immunic shares in Q3 2023, an estimated $774K.
Deep Track Capital first reported a position in Immunic in Q1 2023 and held it in 2 quarters.
Deep Track Capital's Immunic position peaked at $3.76M in Q1 2023.
53 funds tracked by Wall St. Rank held Immunic as of Q3 2023.

Based on Deep Track Capital's 13F filing for Q3 2023, filed 14 Nov 2023.